Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 28-06-1999 |
Asset Class: Equity |
Benchmark: BSE Healthcare TRI |
TER: 2.25% As on (31-10-2024) |
Status: Open Ended Schemes |
Minimum Investment: 5000.0 |
Minimum Topup: 1000.0 |
Total Assets: 1,187.02 Cr As on 31-10-2024(Source:AMFI) |
Turn over: 27% | Exit Load: :� 1.00% if redeemed before 30 days from the date of investment. No on or after 30 days from the date of investment. |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
An open-end fund which exclusively invests in the equities of the pharma & healthcare sector companies. This fund is one of the growth sector fund s aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and health care products and service.
Standard Deviation | 14.3 |
Sharpe Ratio | 0.49 |
Alpha | -0.58 |
Beta | 0.92 |
Yield to Maturity | - |
Average Maturity | - |
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Small Cap
39.04%
Others
1.53%
Large Cap
32.81%
Mid Cap
26.59%